How China’s fast-changing data regulatory environment could influence pharma and life sciences companies’ growth plans | PwC's Next in Health
Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with PwC's Global Pharmaceutical and Life Sciences Cyber Leader, Nalneesh Gaur and PwC's Cybersecurity Principal, Robbie Higgins, on cybersecurity issues and privacy laws that pharmaceuticals and life sciences companies are dealing with in China. This episode includes insights and implications of:
- China Cybersecurity Law
- Multi-layer Protection Scheme 2.0
- Data Security Law
- Personal Information Protection Law
Speaker
Trine Tsouderos
Igor Belokrinitsky
Company
PwC Health Research Institute
Strategy&, PwC
Event Webpage (Available for subscribers only)
Category(s): Health Policy and Regulatory, Pharmaceutical
Format
Podcast
Contact Speaker / Organization (Available for subscribers only)